Exercise now proven to have mental health benefits for prostate cancer

February 15, 2021

New Edith Cowan University (ECU) research has found that exercise not only has physical benefits for men with prostate cancer, it also helps reduce symptoms of depression and anxiety.

Up to one in four men experience anxiety either before or after prostate cancer treatment and up to one in five report depression, although few men access the support they need.

The study, published in the Nature journal Prostate Cancer and Prostatic Diseases, is the first randomised controlled trial to examine the long-term effects of different exercise on psychological distress in men with prostate cancer undergoing androgen deprivation therapy (ADT).

Researchers randomly selected 135 prostate cancer patients aged 43-90 years on ADT to receive either twice weekly supervised resistance exercise or aerobic exercise for 12 months. Their levels of psychological distress were measured during that time.

Key findings: Director of the ECU Exercise Medicine Research Institute Professor Daniel Galvão said the study's findings have immediate applications for people living with prostate cancer.

"We now have the data to support the long-term effect of different exercise modes on psychological distress in men with prostate cancer undertaking ADT," Professor Galvão said.

"Whether you do aerobic exercise or resistance exercise it doesn't matter, as long as it's at moderate to high intensity, it's beneficial for reducing symptoms of depression and anxiety."

"We know that exercise benefits people with cancer. Getting a prescribed exercise program is as simple as a referral from a GP to an Accredited Exercise Physiologist," Professor Galvão said.
-end-
This research is another important outcome from the National Health and Medical Research Council (NHMRC) Centre for Research Excellence (CRE) in Prostate Cancer Survivorship and a significant addition to the Psychosocial Model of Care for Men with Prostate Cancer developed by Prostate Cancer Foundation of Australia and the CRE.

The paper 'Psychological distress in men with prostate cancer undertaking androgen deprivation therapy: modifying effects of exercise from a year-long randomized controlled trial' was published in the journal Prostate Cancer and Prostatic Diseases in Nature. The study was funded by the National Health and Medical Research Council (NHMRC) 534409, Prostate Cancer Foundation of Australia (PCFA), Cancer Council of Western Australia and Cancer Council of Queensland.

Media contact:

Tori Pree, Communications Coordinator, 08 6304 2208, t.pree@ecu.edu.au

Email us to subscribe to our media release mailing list.

For the latest research news delivered to your inbox, register for our fortnightly newsletter.

Edith Cowan University

Related Prostate Cancer Articles from Brightsurf:

Low risk of cancer spread on active surveillance for early prostate cancer
Men undergoing active surveillance for prostate cancer have very low rates - one percent or less - of cancer spread (metastases) or death from prostate cancer, according to a recent study published in the Journal of Urology®, an Official Journal of the American Urological Association (AUA).

ESMO 2020: Breast cancer drug set to transform prostate cancer treatment
A drug used to treat breast and ovarian cancer can extend the lives of some men with prostate cancer and should become a new standard treatment for the disease, concludes a major trial which is set to change clinical practice.

Major trial shows breast cancer drug can hit prostate cancer Achilles heel
A drug already licensed for the treatment of breast and ovarian cancers is more effective than targeted hormone therapy at keeping cancer in check in some men with advanced prostate cancer, a major clinical trial reports.

The Lancet: Prostate cancer study finds molecular imaging could transform management of patients with aggressive cancer
Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical practice.

Common genetic defect in prostate cancer inspires path to new anti-cancer drugs
Researchers found that, in prostate cancer, a mutation leading to the loss of one allele of a tumor suppressor gene known as PPP2R2A is enough to worsen a tumor caused by other mutations.

First prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial.

Men taking medications for enlarged prostate face delays in prostate cancer diagnosis
University of California San Diego School of Medicine researchers report that men treated with medications for benign prostatic hyperplasia (enlarged prostate) experienced a two-year delay in diagnosis of their prostate cancer and were twice as likely to have advanced disease upon diagnosis.

CNIO researchers confirm links between aggressive prostate cancer and hereditary breast cancer
The study has potential implications for families with members suffering from these types of tumours who are at an increased risk of developing cancer.

Distinguishing fatal prostate cancer from 'manageable' cancer now possible
Scientists at the University of York have found a way of distinguishing between fatal prostate cancer and manageable cancer, which could reduce unnecessary surgeries and radiotherapy.

Researchers find prostate cancer drug byproduct can fuel cancer cells
A genetic anomaly in certain men with prostate cancer may impact their response to common drugs used to treat the disease, according to new research at Cleveland Clinic.

Read More: Prostate Cancer News and Prostate Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.